We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VanEck Associates
101
VanEck Associates
New York
$14.6M +$15.2M +157,918 New
Mackenzie Financial
102
Mackenzie Financial
Ontario, Canada
$14.2M +$14.8M +154,050 New
ICM
103
IronBridge Capital Management
Illinois
$14.1M +$14.7M +152,913 New
Caisse de Depot et Placement du Quebec (CDPQ)
104
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$13.8M +$14.4M +149,220 New
FAM
105
Fred Alger Management
New York
$13.7M +$14.3M +148,098 New
SIA
106
Sit Investment Associates
Minnesota
$13.2M +$13.8M +143,385 New
CIP
107
Chartwell Investment Partners
Pennsylvania
$12.8M +$13.4M +138,950 New
Bank of Montreal
108
Bank of Montreal
Ontario, Canada
$12.8M +$13.4M +138,653 New
Chevy Chase Trust
109
Chevy Chase Trust
Maryland
$12.7M +$13.3M +137,707 New
BNP Paribas Financial Markets
110
BNP Paribas Financial Markets
France
$12M +$12.5M +130,062 New
DBG
111
De Burlo Group
Massachusetts
$12M +$12.5M +129,825 New
MLICM
112
Metropolitan Life Insurance Company (MetLife)
New York
$11.9M +$12.5M +129,254 New
D.E. Shaw & Co
113
D.E. Shaw & Co
New York
$11.7M +$12.2M +126,871 New
EAM
114
EULAV Asset Management
Florida
$11.5M +$12M +124,600 New
CA
115
Commerzbank Aktiengesellschaft
Germany
$11.4M +$12M +124,042 New
BCIM
116
British Columbia Investment Management
British Columbia, Canada
$10.9M +$11.4M +118,475 New
Nordea Investment Management
117
Nordea Investment Management
Sweden
$10.7M +$11.2M +115,994 New
Retirement Systems of Alabama
118
Retirement Systems of Alabama
Alabama
$10.6M +$11.1M +115,368 New
Royal Bank of Canada
119
Royal Bank of Canada
Ontario, Canada
$10.6M +$11.1M +114,807 New
RFC
120
Russell Frank Company
Washington
$10.5M +$11M +113,918 New
PP
121
PDT Partners
New York
$10.4M +$10.9M +113,159 New
ARTA
122
A.R.T. Advisors
New York
$10.4M +$10.9M +112,888 New
B
123
Baird
Wisconsin
$9.94M +$10.4M +107,725 New
TG
124
TCW Group
California
$9.65M +$10.1M +104,670 New
QBFM
125
QS Batterymarch Financial Management
New York
$9.49M +$9.92M +102,906 New
3 4
5
6 7

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.